Anna Burgner is a Nephrology physician affiliated with Vanderbilt University Medical Center. OpenAlex indexes 61 publications with 1,025 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1161 21st Ave. South, S-3223 Mcal
Vanderbilt University Medical Center
Nashville, TN 372322372
Telephone
615-322-6976Provider last certified this registry record 21 Mar 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20241 payment
- Travere Therapeutics, Inc.Program year20237 payments
- Vifor Pharma, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
51.1%Calcium channel blocker9.9%Nifedipine Er66%Amlodipine Besylate34%Part D≥24 patientsLoop diuretic8.9%Furosemide64%Torsemide21%Bumetanide15%Part D<11 patients+ 10 more classes in this area
Metabolism & gastrointestinal
22.5%Potassium supplement5.3%Potassium Chloride100%Part D<11 patientsVitamin D3 Analog4.6%Calcitriol100%Part D≥17 patients+ 6 more classes in this area
Blood & clotting
9.3%Solutions for parenteral nutrition5%Calcium Acetate100%Part D≥17 patientsSalt solutions2.7%Sodium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Review of Program Signaling Effects, Perceptions, and Trends for Medical Residencies
Journal of Graduate Medical Education
2025 - Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
Frontiers in Pediatrics
2025 - Current State and Future Direction of Vascular Access Training in the United States
Clinical Journal of the American Society of Nephrology
2025 - Daptomycin-Induced Hyperkalemia in the Absence of Creatinine Kinase Elevation: A Challenging Diagnosis in a Patient with Diabetes and Acute on Chronic CKD
Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center
Brian Rini, MD
Vanderbilt University Medical Center
William Schaffner, MD
Vanderbilt University Medical Center
Jordan Berlin, MD
Vanderbilt University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”